ThinkEquity Initiates Coverage on Inverness Medical (IMA) with a Buy
More News related to IMA
- Capstone initiates Coverage on Inverness Medical Innovations (IMA) with a Buy
- Inverness Medical Innovations (IMA) Posts Q3 EPS of $0.74
- Inverness Medical Innovations Announces Third Quarter 2009 Results
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Newly Acquired Free & Clear Announces Joint Collaboration with the American Cancer Society to Reduce Tobacco Use
ThinkEquity initiates coverage on Inverness Medical (NYSE: IMA) with a Buy. Price target $42.
To see more analyst ratings on IMA Click Here.
Inverness Medical Innovations, Inc. is a global developer, manufacturer and marketer of advanced consumer and professional medical diagnostic products.
Related Categories
New CoverageStocks Mentioned
+0.49Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
